This Week on NeurologyLive

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week.

A feature story from NeurologyLive's October 2020 print issue covering the complex challenges in addressing sleep-disordered breathing, and the current alternative approaches being explored to overcome them, goes live Monday. In the piece, Nicola Davies, PhD, discusses how addressing sleep apnea at a physiological level may reasonably be more effective and have fewer adverse effects than more traditional treatment modalities that may only target one mechanism.

To read the entire October issue online, click here, or to download it in PDF form, click here.

A new Q&A series dedicated to conversations with leaders in the neurology community, called NeuroVoices, premieres with the first half of a discussion with Jennifer Frontera, MD, professor of neurology, NYU Langone Grossman School of Medicine. She discussed the results of a recent study she and colleagues conducted which revealed a number of new neurologic symptoms associated with COVID-19 infection in patients.

To gain insights gleaned from Frontera in previous interviews, click here.

A conversation with Howard Fillit, MD, founding executive director and chief science officer, Alzheimer's Drug Discovery Foundation (ADDF), will air on NeurologyLive's segment on the Medical World News channel this Thursday, October 29, 2020. Fillit discussed the recent ADDF International Conference, highlighting some of the key presentations and offering insights on the state of boundary-pushing research in Alzheimer.

To check out our latest conversations with Fillit, click here.

In partnership with the Consortium of Multiple Sclerosis Centers (CMSC) and the International Organization for Multiple Sclerosis Nurses (IOMSN), the final installment of a webcast program on multiple sclerosis (MS) taking place this month titled, "Cannabis and MS: Helping Patients Understand Risks and Benefits," will air this Wednesday, October 28, at 7PM EDT. This progressive webcast series features Allen C. Bowling, MD, PhD, director of the NeuroHealth Institute and clinical professor of neurology at the University of Colorado. Participants will earn 1 CE credit for each session completed.

To register for the webinar, click here.

Segment 4 of the “Rapid Readout: Expert Perspectives on Multiple Sclerosis” News Network series featuring Mark Freedman, MD, MSc, will air this week. Freedman gave an overview of the phase 3 OPTIMUM study involving ponesimod and how the reduction in MRI-based outcomes, including brain atrophy, is significant in supporting the clinical outcome of relapse rate reduction in patients with relapsing-remitting multiple sclerosis.

To check out the whole series, click here.